Target intelligence / Profile preview

FHAD1 antisense RNA 1 (FHAD1-AS1)

Target
FHAD1-AS1
Molecular classification
Other (Long non-coding RNA)
01

Overview

FHAD1 antisense RNA 1 (FHAD1-AS1) is a long non-coding RNA (lncRNA) that is transcribed antisense to the coding gene FHAD1 (forkhead-associated phosphopeptide binding domain 1). There is currently no substantive publicly available information detailing its established biological function, roles in disease, druggability, or any recognized role as a receptor, enzyme, transporter, or therapeutic target.\n\nThe submitted target "FHAD1 antisense RNA 1 (FHAD1-AS1)" does not match any established therapeutic target class, such as receptor, transporter, or enzyme, nor does it correspond to any major drug target. Available literature and curated gene/protein databases focus on *FHAD1*, a protein-coding gene with a forkhead-associated domain, but not on the antisense RNA (FHAD1-AS1). There is no evidence that FHAD1-AS1 (the antisense lncRNA) is a therapeutic target, biomarker, or implicated directly in any disease, nor is it discussed as a molecule interacting with drugs in the provided or canonical sources. Most available data pertains to the coding gene FHAD1, not its antisense RNA, indicating that FHAD1-AS1 may be either rarely studied or possibly misidentified as a target.\n\nIn summary, FHAD1 antisense RNA 1 (FHAD1-AS1) is a putative long non-coding RNA; current evidence does not support its identification as a validated therapeutic target, nor does it have well-documented biological functions or disease associations in the literature. If you are seeking information on the protein-coding FHAD1 gene/protein, detailed and structured data is available; however, that is a distinct entity from "FHAD1 antisense RNA 1" and should not be conflated.

Other names
FHAD1-AS1
02

Biological functions

Unknown
03

Disease associations

Unknown

Beyond the preview

Go deeper on FHAD1 antisense RNA 1 (FHAD1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FHAD1 antisense RNA 1 (FHAD1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call